e-learning
resources
Barcelona 2010
Sunday, 19.09.2010
Clinical issues in diffuse parenchymal lung disease
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Late Breaking Abstract: Non-steroid agents for idiopathic pulmonary fibrosis: A systematic review
P. Spagnolo, C. Del Giovane, F. Luppi, S. Cerri, S. Balduzzi, E. H. Walters, R. D‘Amico, L. Richeldi (Modena, Italy; Hobart, Australia)
Source:
Annual Congress 2010 - Clinical issues in diffuse parenchymal lung disease
Session:
Clinical issues in diffuse parenchymal lung disease
Session type:
Thematic Poster Session
Number:
825
Disease area:
Interstitial lung diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
P. Spagnolo, C. Del Giovane, F. Luppi, S. Cerri, S. Balduzzi, E. H. Walters, R. D‘Amico, L. Richeldi (Modena, Italy; Hobart, Australia). Late Breaking Abstract: Non-steroid agents for idiopathic pulmonary fibrosis: A systematic review. Eur Respir J 2010; 36: Suppl. 54, 825
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Panel discussion: ANCA associated vasculitis and lung disease
Panel discussion on genetics in pulmonary fibrosis
The Relationship Between Functional Status and Fatigue After COVID-19 Infection
Related content which might interest you:
Prognosis of idiopathic pulmonary fibrosis without anti-fibrotic therapy: a systematic review
Source: Eur Respir Rev, 29 (157) 190158; 10.1183/16000617.0158-2019
Year: 2020
Comorbidities in idiopathic pulmonary fibrosis patients: a systematic literature review
Source: Eur Respir J 2015; 46: 1113-1130
Year: 2015
Late Breaking Abstract - Idiopathic Pulmonary Fibrosis – a worldwide review of ‘real’ life’ practice: experience from a treatment feasibility review in 41 countries
Source: International Congress 2018 – ILDs: From bench to bedside
Year: 2018
The clinical efficacy of pulmonary hypertension-specific agents in idiopathic pulmonary fibrosis: A systematic review and meta-analysis
Source: International Congress 2019 – Treatment and prognosis of idiopathic interstitial pneumonia
Year: 2019
Late Breaking Abstract - COPD patient´s adherence to pulmonary rehabilitation programs: scoping review
Source: Virtual Congress 2021 – Pulmonary rehabilitation in asthma and COPD
Year: 2021
Late Breaking Abstract - Evaluating the feasibility, safety, and efficacy of senolytics in idiopathic pulmonary fibrosis
Source: International Congress 2019 – Idiopathic pulmonary fibrosis and surroundings
Year: 2019
Late Breaking Abstract - Survival and course of lung function in patients with idiopathic pulmonary fibrosis with or without antifibrotic treatment: long-term results of the INSIGHTS-IPF registry
Source: International Congress 2019 – Idiopathic pulmonary fibrosis and surroundings
Year: 2019
Late Breaking Abstract - Tocilizumab administration for the treatment of hospitalised patients with COVID-19: A systematic review and meta-analysis
Source: Virtual Congress 2021 – Challenges of COVID-19 management at short and long-term
Year: 2021
Global incidence and mortality of idiopathic pulmonary fibrosis: a systematic review
Source: Eur Respir J 2015; 46: 795-806
Year: 2015
Late Breaking Abstract - The humanistic burden of asthma patients uncontrolled on ICS-LABA: a systematic literature review
Source: Virtual Congress 2020 – Inhaled corticosteroids and bronchodilator studies in asthma
Year: 2020
Idiopathic pulmonary fibrosis: recent milestones in disease management
Source: Eur Respir Rev 2012; 21: 140
Year: 2012
Idiopathic pulmonary fibrosis trials: recommendations for the jury
Source: Eur Respir J 2011; 38: 1002-1004
Year: 2011
Late Breaking Abstract - Update the evidence about thirdhand smoke: a systematic review.
Source: International Congress 2018 – Novel findings in biomarkers of tobacco use, exposure, hazards and genetics
Year: 2018
Late Breaking Abstract - Use of mepolizumab in bronchiectasis with underlying eosinophilic condition
Source: International Congress 2018 – New methods for diagnosing and treating lung diseases
Year: 2018
Reply to: Malnutrition in idiopathic pulmonary fibrosis: the great forgotten comorbidity!
Source: Eur Respir J, 53 (5) 1900615; 10.1183/13993003.00615-2019
Year: 2019
Late Breaking Abstract - Long-term Effect of Pulmonary Rehabilitation under Nintedanib treatment in Idiopathic Pulmonary Fibrosis (FITNESS study)
Source: Virtual Congress 2021 – ALERT: Asthma in adult, in children and ILDs
Year: 2021
Pirfenidone post-authorization safety registry (PASSPORT) update
Source: International Congress 2015 – Treatment of IPF
Year: 2015
Late Breaking Abstract - Defining a severe asthma super-responder: findings from a Delphi process
Source: Virtual Congress 2020 – Advances in asthma treatment
Year: 2020
Management of idiopathic pulmonary fibrosis: selected case reports
Source: Eur Respir Rev 2014; 23:239-248
Year: 2014
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept